Toll like receptors signaling pathways as a target for therapeutic interventions

Gnieszka AJezierska, Irina A. Kolosova, Alexander D. Verin

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

This review summarizes the key role of Toll-Like Receptor (TLRs) molecules for igniting the immune system. Activated by a broad spectrum of pathogens, cytokines or other specific molecules, TLRs trigger innate immune responses. Published data demonstrate that the targeting and suppression of TLRs and TLR-related proteins with particular inhibitors may provide pivotal treatments for patients with cancer, asthma, sepsis, Crohn's disease and thrombosis. Many drugs that target cytokines act in the late phases of the activated pathways, after the final peptides, proteins or glycoproteins are formed in the cell environment. TLR activity occurs in the early activation of cellular pathways; consequently inhibiting them might be most beneficial in the treatment of human diseases.

Original languageEnglish (US)
Pages (from-to)428-440
Number of pages13
JournalCurrent Signal Transduction Therapy
Volume6
Issue number3
DOIs
StatePublished - Sep 1 2011

Fingerprint

Toll-Like Receptors
Cytokines
Therapeutics
Innate Immunity
Crohn Disease
Immune System
Sepsis
Glycoproteins
Proteins
Thrombosis
Asthma
Peptides
Pharmaceutical Preparations
Neoplasms

Keywords

  • Signaling pathways
  • TLR
  • Therapy

ASJC Scopus subject areas

  • Endocrinology
  • Pharmacology (medical)

Cite this

Toll like receptors signaling pathways as a target for therapeutic interventions. / AJezierska, Gnieszka; Kolosova, Irina A.; Verin, Alexander D.

In: Current Signal Transduction Therapy, Vol. 6, No. 3, 01.09.2011, p. 428-440.

Research output: Contribution to journalReview article

@article{6b2b25e3cb8c49e6bc0a9cb34244b9bb,
title = "Toll like receptors signaling pathways as a target for therapeutic interventions",
abstract = "This review summarizes the key role of Toll-Like Receptor (TLRs) molecules for igniting the immune system. Activated by a broad spectrum of pathogens, cytokines or other specific molecules, TLRs trigger innate immune responses. Published data demonstrate that the targeting and suppression of TLRs and TLR-related proteins with particular inhibitors may provide pivotal treatments for patients with cancer, asthma, sepsis, Crohn's disease and thrombosis. Many drugs that target cytokines act in the late phases of the activated pathways, after the final peptides, proteins or glycoproteins are formed in the cell environment. TLR activity occurs in the early activation of cellular pathways; consequently inhibiting them might be most beneficial in the treatment of human diseases.",
keywords = "Signaling pathways, TLR, Therapy",
author = "Gnieszka AJezierska and Kolosova, {Irina A.} and Verin, {Alexander D.}",
year = "2011",
month = "9",
day = "1",
doi = "10.2174/157436211797483930",
language = "English (US)",
volume = "6",
pages = "428--440",
journal = "Current Signal Transduction Therapy",
issn = "1574-3624",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Toll like receptors signaling pathways as a target for therapeutic interventions

AU - AJezierska, Gnieszka

AU - Kolosova, Irina A.

AU - Verin, Alexander D.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - This review summarizes the key role of Toll-Like Receptor (TLRs) molecules for igniting the immune system. Activated by a broad spectrum of pathogens, cytokines or other specific molecules, TLRs trigger innate immune responses. Published data demonstrate that the targeting and suppression of TLRs and TLR-related proteins with particular inhibitors may provide pivotal treatments for patients with cancer, asthma, sepsis, Crohn's disease and thrombosis. Many drugs that target cytokines act in the late phases of the activated pathways, after the final peptides, proteins or glycoproteins are formed in the cell environment. TLR activity occurs in the early activation of cellular pathways; consequently inhibiting them might be most beneficial in the treatment of human diseases.

AB - This review summarizes the key role of Toll-Like Receptor (TLRs) molecules for igniting the immune system. Activated by a broad spectrum of pathogens, cytokines or other specific molecules, TLRs trigger innate immune responses. Published data demonstrate that the targeting and suppression of TLRs and TLR-related proteins with particular inhibitors may provide pivotal treatments for patients with cancer, asthma, sepsis, Crohn's disease and thrombosis. Many drugs that target cytokines act in the late phases of the activated pathways, after the final peptides, proteins or glycoproteins are formed in the cell environment. TLR activity occurs in the early activation of cellular pathways; consequently inhibiting them might be most beneficial in the treatment of human diseases.

KW - Signaling pathways

KW - TLR

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=80054943009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054943009&partnerID=8YFLogxK

U2 - 10.2174/157436211797483930

DO - 10.2174/157436211797483930

M3 - Review article

AN - SCOPUS:80054943009

VL - 6

SP - 428

EP - 440

JO - Current Signal Transduction Therapy

JF - Current Signal Transduction Therapy

SN - 1574-3624

IS - 3

ER -